11-62856275-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_001012662.3(SLC3A2):c.6G>A(p.Glu2Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000683 in 1,611,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000035 ( 0 hom. )
Consequence
SLC3A2
NM_001012662.3 synonymous
NM_001012662.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.862
Genes affected
SLC3A2 (HGNC:11026): (solute carrier family 3 member 2) This gene is a member of the solute carrier family and encodes a cell surface, transmembrane protein. The protein exists as the heavy chain of a heterodimer, covalently bound through di-sulfide bonds to one of several possible light chains. The encoded transporter plays a role in regulation of intracellular calcium levels and transports L-type amino acids. Alternatively spliced transcript variants, encoding different isoforms, have been characterized. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 11-62856275-G-A is Benign according to our data. Variant chr11-62856275-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3164749.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.862 with no splicing effect.
BS2
High AC in GnomAd4 at 59 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC3A2 | NM_001012662.3 | c.6G>A | p.Glu2Glu | synonymous_variant | 1/12 | NP_001012680.1 | ||
SLC3A2 | NM_002394.6 | c.6G>A | p.Glu2Glu | synonymous_variant | 1/12 | NP_002385.3 | ||
SLC3A2 | NM_001012664.3 | c.6G>A | p.Glu2Glu | synonymous_variant | 1/10 | NP_001012682.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC3A2 | ENST00000377890.6 | c.6G>A | p.Glu2Glu | synonymous_variant | 1/12 | 1 | ENSP00000367122.2 | |||
SLC3A2 | ENST00000377889.6 | c.6G>A | p.Glu2Glu | synonymous_variant | 1/10 | 1 | ENSP00000367121.2 | |||
SLC3A2 | ENST00000538084.2 | c.6G>A | p.Glu2Glu | synonymous_variant | 1/13 | 3 | ENSP00000440001.2 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152236Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
59
AN:
152236
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000678 AC: 17AN: 250766Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135554
GnomAD3 exomes
AF:
AC:
17
AN:
250766
Hom.:
AF XY:
AC XY:
3
AN XY:
135554
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000350 AC: 51AN: 1458672Hom.: 0 Cov.: 30 AF XY: 0.0000262 AC XY: 19AN XY: 725086
GnomAD4 exome
AF:
AC:
51
AN:
1458672
Hom.:
Cov.:
30
AF XY:
AC XY:
19
AN XY:
725086
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000387 AC: 59AN: 152354Hom.: 0 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74506
GnomAD4 genome
AF:
AC:
59
AN:
152354
Hom.:
Cov.:
33
AF XY:
AC XY:
28
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at